Kazuhiko Mishima
- Oncology top 2%
- Molecular Biology top 10%
- Genetics top 1%
- Surgery top 10%
- Immunology top 5%
- Co-authors
- Yukinari KatoMika K. KanekoRyo NishikawaYoshitaka NaritaHisashi NarimatsuMasao MatsutaniWebster K. CaveneeTakaaki Kirino
- Topics
- Glioma Diagnosis and Treatment (36 papers)CNS Lymphoma Diagnosis and Treatment (18 papers)Lymphoma Diagnosis and Treatment (10 papers)
- Cited by
- GeneticsOncologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyJournal of Biological Chemistry
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Kazuhiko Mishima
82 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 99
- Oncology 1.3k
- Molecular Biology 1.2k
- Genetics 662
- Surgery 521
- Immunology 437
Countries citing papers authored by Kazuhiko Mishima
This map shows the geographic impact of Kazuhiko Mishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiko Mishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiko Mishima more than expected).
Fields of papers citing papers by Kazuhiko Mishima
This network shows the impact of papers produced by Kazuhiko Mishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiko Mishima. The network helps show where Kazuhiko Mishima may publish in the future.
Co-authorship network of co-authors of Kazuhiko Mishima
This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiko Mishima. A scholar is included among the top collaborators of Kazuhiko Mishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiko Mishima. Kazuhiko Mishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 0 | |
| 9 | 2 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 1 | |
| 13 | 13 | |
| 14 | 23 | |
| 15 | 402 | |
| 16 | 11 | |
| 17 | 195 | |
| 18 | 67 | |
| 19 | 36 | |
| 20 | 93 |
About Kazuhiko Mishima
Kazuhiko Mishima is a scholar working on Genetics, Neurology and Oncology, having authored 90 papers that have together received 2.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (36 papers), CNS Lymphoma Diagnosis and Treatment (18 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Genetics (662 citations), Oncology (1.3k citations) and Cancer Research (353 citations). Kazuhiko Mishima has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yukinari Kato, Mika K. Kaneko, Ryo Nishikawa, Yoshitaka Narita, Hisashi Narimatsu, Masao Matsutani, Webster K. Cavenee, Takaaki Kirino, Motoo Nagane and Akio Asai. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.